Is it safe to prescribe glucagon-like peptide1 (GLP1) receptor agonists for weight loss or glycemic control in a patient with diverticulosis?
If any product remains, it should be stored closed in the refrigerator anduses one week after open
Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al
Patients who switched from tirzepatide to orforglipron maintained their previously achieved weight loss with an average difference of only 5.0 kg at 52 weeks
In the case of organic compounds, biotransformation steps are often necessary and their nature, mechanism(s), responsible enzymes and related polymorphisms are well characterized and the respective role in determining individual sensitivity to the effects of exposure at different levels is a well-established field of investigation